Evidence map›Paper›PMID 28495983›Full record

ArticleCirculation research2017

Immunomodulation Is the Key to Cardiac Repair.

Tariq Hamid, Sumanth D Prabhu

Abstract readEditorialComment
In one paragraph

Article in Circulation research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. New treatment methods for myocardial infarction.Frontiers in cardiovascular medicine · 2023
    Review
  2. Regenerative medicine technologies applied to transplant medicine. An update.Frontiers in bioengineering and biotechnology · 2022
    Review
  3. Review
  4. Once-yearly zoledronic acid and change in abdominal aortic calcification over 3 years in postmenopausal women with osteoporosis: results from the HORIZON Pivotal Fracture Trial.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2020
    Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Tariq HamidFrom the Division of Cardiovascular Disease, Department of Medicine, University of Alabama at Birmingham, and Medical Service, Birmingham VAMC.
Sumanth D PrabhuFrom the Division of Cardiovascular Disease, Department of Medicine, University of Alabama at Birmingham, and Medical Service, Birmingham VAMC. sprabhu@uab.edu.

Funding

Splenic Marginal Zone Macrophages in Chronic Ischemic Heart FailureR01HL125735 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI PRABHU, SUMANTH D · 2015 to 2018
$1.5M
Role of Regulatory T-Lymphocytes in Chronic Heart FailureI01BX002706 · VA · BIRMINGHAM VA MEDICAL CENTER · PI PRABHU, SUMANTH D · 2015 to 2018
–
BLRD VA I01 BX002706NHLBI NIH HHS R01 HL125735
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CardiomyopathiesMesenchymal Stem CellsMyocardial InfarctionVentricular Dysfunction, LeftAnti-Inflammatory AgentsHumansImmunomodulationAnti-Inflammatory Agentscell therapyEditorialsimmunomodulationinflammationmesenchymal stem cellsmyocardial infarction

Identifiers

PMID28495983
PMCPMC5604853

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.